Viewing nowKongbrukjeong 2.5 mg (Bisoprolol Fumarate)
Bisoprolol Fumarate 2.5mg
Tablet · Prescription medication
EriSun Pharmaceutical Co., Ltd.

MFDS item code 201404183 · Approved 2014.09.11 · Insurance code 620500110
Treatment of stable chronic heart failure with reduced left ventricular systolic function
This medication is used for the treatment of stable chronic heart failure with reduced left ventricular systolic function. It is mainly administered in conjunction with ACE inhibitors and diuretics, and may also be combined with cardiac glycosides as needed to alleviate symptoms and improve heart function. This can enhance the quality of life for heart failure patients and prevent the worsening of symptoms.
Take in the morning on an empty stomach or with breakfast, with a drink. Do not chew. Stable chronic heart failure Adults: Administer orally once daily, increasing the dose of bisoprolol fumarate as follows. Treatment with this medicine should be initiated only when the patient is in a stable condition without acute symptoms of heart failure. Dose titration The initial dose of this medicine is 1.25mg once daily. Assess tolerability and gradually increase the dose in the following order: 2.5mg, 3.75mg, 5mg, 7.5mg, and 10mg, allowing at least 2 weeks between each dose increase. The maintenance dose is 10mg once daily. The recommended maximum daily dose is 10mg once daily. During dose titration, closely monitor the patient's condition, including blood pressure and heart rate, and whether symptoms of heart failure worsen. Dose adjustment during treatment If the maximum recommended dose is poorly tolerated, consider gradually reducing the dose. If transient worsening of heart failure symptoms, hypotension, or bradycardia occurs, adjustment of the doses of concomitant medicines is recommended. If necessary, temporary dose reduction or discontinuation of this medicine may be required. Once heart failure symptoms have stabilized, consider restarting this medicine or increasing the dose. Because abrupt discontinuation of this medicine may cause acute worsening of heart failure symptoms, gradual dose reduction is recommended. Treatment of stable chronic heart failure with this medicine is generally long-term. Patients with hepatic or renal impairment Pharmacokinetic information is not available for patients with chronic heart failure who have these conditions; therefore, use particular caution when increasing the dose in these patients. Older adults No dose adjustment is necessary.
Use is not recommended because there is no experience with this medicine in children.
This medication lacks sufficient usage experience in patients with certain heart diseases or severely impaired kidney or liver function, and should be used with caution. Bronchodilators should be used in patients with bronchial asthma or chronic obstructive pulmonary disease, and caution is needed as asthma patients may experience increased airway resistance. This medication can worsen allergic reactions and may mask symptoms in patients with hyperthyroidism; caution is advised. Abrupt discontinuation can risk worsening heart conditions, so it should be tapered off gradually as directed by a physician. It should not be given to patients with diabetic ketoacidosis, severe bradycardia, cardiogenic shock, acute heart failure, and other specific conditions. Women who are pregnant or may become pregnant should avoid using this medication as it can be harmful to the fetus. If nursing, it is advisable to either avoid this medication due to its potential secretion in breast milk or stop breastfeeding. Safety in pediatric patients has not been confirmed, so its use is not recommended. In the elderly, it should be started at a low dose while closely monitoring their condition. This medication can interact with other drugs, so patients must inform their doctor of all medications they are taking, especially when using with calcium channel blockers, central nervous system drugs, insulin, etc. Caution is needed while driving or operating machinery due to individual variations, particularly early in treatment or during medication changes. Overdose can result in severe bradycardia, hypotension, and bronchospasm; immediate medical attention is needed.
Bradycardia, worsening of heart failure, coldness or numbness in limbs, hypotension, dizziness, headache, nausea, vomiting, diarrhea, constipation, weakness, fatigue, atrioventricular conduction disorder, orthostatic hypotension, sleep disturbances, depression, bronchospasm, muscle atrophy and spasms, nightmares, hallucinations, decreased tear production, hearing impairment, allergic rhinitis, hypersensitivity reactions (itching, redness, rash), hepatitis, sexual dysfunction, conjunctivitis, exacerbation of psoriasis or psoriasis-like rash, hair loss
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is best to maintain the storage temperature between 1 and 30 degrees Celsius.
White film-coated tablet, heart-shaped, convex on both sides with a score line on one side
30 tablets/bottle, 300 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowBisoprolol Fumarate 2.5mg
Tablet · Prescription medication
EriSun Pharmaceutical Co., Ltd.

Bisoprolol Fumarate 5mg
Tablet · Prescription medication
Merck Co., Ltd.

Bisoprolol Fumarate 2.5mg
Tablet · Prescription medication
Merck Co., Ltd.

Bisoprolol Fumarate 5mg
Tablet · Prescription medication
Celix Co., Ltd.

Bisoprolol Fumarate 5mg
Tablet · Prescription medication
Ilhwa Co., Ltd.

Bisoprolol Fumarate 5mg
Tablet · Prescription medication
Samchundang Pharmaceutical Co., Ltd.

Bisoprolol Fumarate 5mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.

Bisoprolol Fumarate 5mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.